Alexandra Franco Garcia, MD
Infectious Disease · Winter Garden, FLNPI 1518356203
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,465 of the $1,823 with a category attached, or 80.4%. It is spread thinly across 14 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $619 and has fallen 66.2% since, to $210 in 2023.
Across 77 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$341
- Gilead$274
- AbbVie$271
- Melinta Therapeutics, LLC$213
- Merck$171
- Viiv Healthcare Company$149
- plus $402 from 8 others
What the payments were for
- Food & beverage$1,46580%
- Education$35720%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $341 |
| Gilead | 16 | $274 |
| AbbVie | 8 | $271 |
| Melinta Therapeutics, LLC | 10 | $213 |
| Merck | 5 | $171 |
| Viiv Healthcare Company | 7 | $149 |
| Insmed, Inc. | 5 | $103 |
| Johnson & Johnson | 6 | $101 |
| EMD Serono, Inc. | 5 | $69 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk | 2 | $33 |
| Lilly USA, LLC | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,823 in reported general payments places this provider in the 65th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Winter Garden
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Douglas BrustMiami$359K
- Christopher CooperAltamonte Springs$278K
- Federico HinestrosaOrlando$276K
- Cynthia RiveraMiami Beach$265K
- Sally AlrabaaTampa$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.